Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Clinical trial NCT07346144 · RECRUITING

Trial details

NCT number: NCT07346144
Sponsor: Trogenix ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma (GBM)High Grade Gliomas Recurrent Glioblastoma Newly Diagnosed Glioblastoma

Start date: 2026-04-21
Primary completion: 2030-03-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.